Split History
ETFs Holding CYCC »    CYCC Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cyclacel Pharmaceuticals is a biopharmaceutical company engaged in developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin Dependent Kinase 2/9 (CDK2/9) inhibitor, in solid tumors and hematological malignancies. CDKs also provide pivotal functions in the regulation of transcription, DNA repair and metastatic spread. The anti-mitotic program is evaluating plogosertib, a polo-like kinase, or PLK inhibitor, in solid tumors and hematological malignancies. PLK1 is a serine/threonine kinase with a central role in cell division, or the mitotic phase of the cell cycle. According to our CYCC split history records, Cyclacel Pharmaceuticals has had 4 splits.
CYCC split history picture
Cyclacel Pharmaceuticals (CYCC) has 4 splits in our CYCC split history database. The first split for CYCC took place on August 27, 2012. This was a 1 for 7 reverse split, meaning for each 7 shares of CYCC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 142.857142857143 share position following the split. CYCC's second split took place on May 31, 2016. This was a 1 for 12 reverse split, meaning for each 12 shares of CYCC owned pre-split, the shareholder now owned 1 share. For example, a 142.857142857143 share position pre-split, became a 11.9047619047619 share position following the split. CYCC's third split took place on April 15, 2020. This was a 1 for 20 reverse split, meaning for each 20 shares of CYCC owned pre-split, the shareholder now owned 1 share. For example, a 11.9047619047619 share position pre-split, became a 0.595238095238095 share position following the split. CYCC's 4th split took place on December 18, 2023. This was a 1 for 15 reverse split, meaning for each 15 shares of CYCC owned pre-split, the shareholder now owned 1 share. For example, a 0.595238095238095 share position pre-split, became a 0.0396825396825397 share position following the split.

When a company such as Cyclacel Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the CYCC split history from start to finish, an original position size of 1000 shares would have turned into 0.0396825396825397 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cyclacel Pharmaceuticals shares, starting with a $10,000 purchase of CYCC, presented on a split-history-adjusted basis factoring in the complete CYCC split history. CYCC split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/28/2014
End date: 05/23/2024
Start price/share: $11,772.00
End price/share: $2.05
Dividends collected/share: $0.00
Total return: -99.98%
Average Annual Total Return: -57.94%
Starting investment: $10,000.00
Ending investment: $1.74
Years: 9.99
Date Ratio
08/27/20121 for 7
05/31/20161 for 12
04/15/20201 for 20
12/18/20231 for 15
CYCC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CYH Split History
CYTK Split History
CYTR Split History
CYTX Split History
DARA Split History
DCTH Split History
DFFN Split History
DGX Split History
DHR Split History
DMPI Split History

Also explore: CYCC shares outstanding history

Email EnvelopeFree CYCC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Tharimmune, Inc. (THAR)
BioCardia, Inc. (BCDA)
Lam Research Corporation (LRCX)
Akanda Corp. (AKAN)
Amphenol Corporation (APH)
Jaguar Health, Inc. (JAGX)
OpGen, Inc. (OPGN)
Blue Star Foods Corp. (BSFC)
Charles & Colvard, Ltd. (CTHR)
Seelos Therapeutics, Inc. (SEEL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CYCC Insider Buying

CYCC Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.